APA Zitierstil

Kosenko, T., Golder, M., Leblond, G., Weng, W., & Lagace, T. A. (2013). Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation. American Society for Biochemistry and Molecular Biology.

Chicago Zitierstil

Kosenko, Tanja, Mia Golder, Geoffrey Leblond, Willy Weng, und Thomas A. Lagace. Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation. American Society for Biochemistry and Molecular Biology, 2013.

MLA Zitierstil

Kosenko, Tanja, et al. Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation. American Society for Biochemistry and Molecular Biology, 2013.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.